Compound index
Twenty launch entities selected from search demand and audience interest. Counts include published reports only. Pages with fewer than five reports hold percentages until the sample threshold is met.
A synthetic peptide discussed in experimental recovery research and public experience reports.
View 4 reports →A synthetic racetam compound discussed in nootropic communities and limited research literature.
View 0 reports →A botanical supplement used in products focused on stress, sleep, and physical performance.
View 0 reports →A synthetic growth-hormone-releasing hormone analogue discussed in experimental performance contexts.
View 0 reports →A dietary compound widely studied in relation to high-intensity performance and muscle energy.
View 0 reports →A copper-binding peptide used in some cosmetic formulations and discussed in skin and hair reports.
View 0 reports →A synthetic growth-hormone-releasing peptide discussed in experimental performance contexts.
View 0 reports →A naturally occurring compound involved in fatty-acid transport and used in supplements and medicines.
View 0 reports →An amino acid found in tea and used in supplements focused on calm attention and sleep.
View 0 reports →A chelated form of magnesium commonly used in supplements focused on magnesium intake and tolerability.
View 0 reports →An active ingredient used in authorised hair-loss products, with topical and oral experiences reported.
View 0 reports →An investigational growth-hormone secretagogue discussed in performance and sleep communities.
View 0 reports →A nucleotide precursor to NAD+ discussed in ageing, energy, and metabolic research.
View 0 reports →A plant oil used as a food supplement and discussed in hair and urinary-health communities.
View 0 reports →A prescription medicine and mTOR inhibitor also discussed in longevity research communities.
View 0 reports →An investigational triple receptor agonist being studied in clinical development.
View 0 reports →An experimental topical antiandrogen discussed in hair-loss communities.
View 0 reports →A GLP-1 receptor agonist available in authorised prescription medicines for specific indications.
View 0 reports →A synthetic peptide associated with thymosin beta-4 and discussed in experimental recovery contexts.
View 0 reports →A GIP and GLP-1 receptor agonist available in authorised prescription medicines for specific indications.
View 0 reports →Aggregated from source-linked public reports. Every indexed report links to its source. This is anecdotal evidence — not clinical data. How we aggregate →